Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 21324133)

1.

Study design and participant characteristics of a randomized controlled trial of directly administered antiretroviral therapy in opioid treatment programs.

Mullen BA, Cook K, Moore RD, Rand C, Galai N, McCaul ME, Glass S, Oursler KK, Lucas GM.

BMC Infect Dis. 2011 Feb 15;11:45. doi: 10.1186/1471-2334-11-45.

2.

Directly administered antiretroviral therapy for HIV-infected individuals in opioid treatment programs: results from a randomized clinical trial.

Lucas GM, Mullen BA, Galai N, Moore RD, Cook K, McCaul ME, Glass S, Oursler KK, Rand C.

PLoS One. 2013 Jul 16;8(7):e68286. doi: 10.1371/journal.pone.0068286. Print 2013.

3.
4.

Persistence of virological benefits following directly administered antiretroviral therapy among drug users: results from a randomized controlled trial.

Maru DS, Bruce RD, Walton M, Springer SA, Altice FL.

J Acquir Immune Defic Syndr. 2009 Feb 1;50(2):176-81. doi: 10.1097/QAI.0b013e3181938e7e.

5.

Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy.

Lucas GM, Mullen BA, McCaul ME, Weidle PJ, Hader S, Moore RD.

AIDS Patient Care STDS. 2007 Aug;21(8):564-74.

PMID:
17711381
6.

A randomized trial of directly administered antiretroviral therapy and adherence case management intervention.

Wohl AR, Garland WH, Valencia R, Squires K, Witt MD, Kovacs A, Larsen R, Hader S, Anthony MN, Weidle PJ.

Clin Infect Dis. 2006 Jun 1;42(11):1619-27. Epub 2006 Apr 28.

7.

Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups.

Lucas GM, Mullen BA, Weidle PJ, Hader S, McCaul ME, Moore RD.

Clin Infect Dis. 2006 Jun 1;42(11):1628-35. Epub 2006 Apr 28.

8.

Targeting candidates for directly administered highly active antiretroviral therapy: benefits observed in HIV-infected injecting drug users in residential drug-rehabilitation facilities.

Babudieri S, Dorrucci M, Boschini A, Carbonara S, Longo B, Monarca R, Ortu F, Congedo P, Soddu A, Maida IR, Caselli F, Madeddu G, Rezza G.

AIDS Patient Care STDS. 2011 Jun;25(6):359-64. doi: 10.1089/apc.2010.0229.

PMID:
21612546
9.
10.

Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replication.

Altice FL, Mezger JA, Hodges J, Bruce RD, Marinovich A, Walton M, Springer SA, Friedland GH.

Clin Infect Dis. 2004 Jun 1;38 Suppl 5:S376-87.

11.

Lack of sustained improvement in adherence or viral load following a directly observed antiretroviral therapy intervention.

Berg KM, Litwin AH, Li X, Heo M, Arnsten JH.

Clin Infect Dis. 2011 Nov;53(9):936-43. doi: 10.1093/cid/cir537. Epub 2011 Sep 2.

12.

Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users.

Smith-Rohrberg D, Mezger J, Walton M, Bruce RD, Altice FL.

J Acquir Immune Defic Syndr. 2006 Dec 1;43 Suppl 1:S48-53.

PMID:
17133204
13.
14.

Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy.

Maru DS, Bruce RD, Walton M, Mezger JA, Springer SA, Shield D, Altice FL.

AIDS Behav. 2008 Mar;12(2):284-93. Epub 2007 Dec 18.

15.

Medication persistence of HIV-infected drug users on directly administered antiretroviral therapy.

Ing EC, Bae JW, Maru DS, Altice FL.

AIDS Behav. 2013 Jan;17(1):113-21. doi: 10.1007/s10461-011-0082-0.

PMID:
22105340
16.

Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study.

Lucas GM, Weidle PJ, Hader S, Moore RD.

Clin Infect Dis. 2004 Jun 1;38 Suppl 5:S409-13.

17.

Directly observed antiretroviral therapy in substance abusers receiving methadone maintenance therapy does not cause increased drug resistance.

Brust JC, Litwin AH, Berg KM, Li X, Heo M, Arnsten JH.

AIDS Res Hum Retroviruses. 2011 May;27(5):535-41. doi: 10.1089/aid.2010.0181. Epub 2010 Nov 23.

18.

A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.

García F, Romeu J, Grau I, Sambeat MA, Dalmau D, Knobel H, Gomez-Sirvent JL, Arrizabalaga J, Cruceta A, Clotet BG, Podzamczer D, Pumarola T, Gallart T, O'Brien WA, Miró JM, Gatell JM.

AIDS. 1999 Dec 3;13(17):2377-88.

PMID:
10597779
19.

Rationale, design, and sample characteristics of a randomized controlled trial of directly observed antiretroviral therapy delivered in methadone clinics.

Berg KM, Mouriz J, Li X, Duggan E, Goldberg U, Arnsten JH.

Contemp Clin Trials. 2009 Sep;30(5):481-9. doi: 10.1016/j.cct.2009.05.003. Epub 2009 Jun 6.

20.

Immune reconstitution in severely immunosuppressed antiretroviral-naive HIV type 1-infected patients using a nonnucleoside reverse transcriptase inhibitor-based or a boosted protease inhibitor-based antiretroviral regimen: three-year results (The Advanz Trial): a randomized, controlled trial.

Miró JM, Manzardo C, Pich J, Domingo P, Ferrer E, Arribas JR, Ribera E, Arrizabalaga J, Loncá M, Cruceta A, de Lazzari E, Fuster M, Podzamczer D, Plana M, Gatell JM; Advanz Study Group.

AIDS Res Hum Retroviruses. 2010 Jul;26(7):747-57. doi: 10.1089/aid.2009.0105.

PMID:
20624069
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk